In September 2025, we selected a new PTH1R development candidate, SEP-479, and we plan to initiate a placebo-controlled, SAD and MAD Phase 1 clinical trial in Australia, pending the successful completion of regulatory submissions in the first half of 2026
This is exactly the kind of conversation we believe compounding pharmacies should be part of, and we're not waiting for the outcome to have a point of view
S-Acetyl Glutathione 200mg
The practice's emphasis on long-term relationships means you'll work with the same provider throughout your journey, building trust and continuity of care
BPC 157 has caught attention because of its potential healing properties, particularly in tissues and muscles
GHK-Cu Research Canada Recent research indicates that GHK-Cu peptide nasal spray has promising therapeutic benefits, particularly in improving cognitive function, reducing inflammation, promoting skin regeneration, and fostering tissue repair
